Evolv Technologies
- Market cap
- 841.33M
- P/E (TTM)i
- -232.25
- P/Bi
- 7.08
- EPSi
- -0.20
- Div yieldi
- 0.00%
- 52W posi
- 4%
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions increased by 1 in the most recent period (2026/Q3).
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 67.83% +0.07pp
- Institutions
- 304 +1
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions added shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Top holders as of 2026-06-30
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 33 buys · 17 sells
| Name | Role | Stake |
|---|---|---|
| William Gates | -- | 1.31% |
| Michael Ellenbogen | Co-Founder, Chief Innovation Officer & Director | 1.23% |
| Anil Chitkara | Co-Founder & Chief Growth Officer | 0.74% |
| Peter George | Chief Executive Officer | 0.52% |
| Mark Donohue | Chief Financial Officer | 0.26% |
| Kevin Charlton | Independent Director | 0.22% |
| Neil Glat | Independent Director | 0.14% |
| Mark Sullivan | Independent Director | 0.13% |
| David Gonzales | Director | 0.11% |
| Richard Shapiro | Director | 0.10% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-03 | Richard Shapiro | Director | Open Market Acquisition | +32,600 | $4.94–4.98 |
| 2026-08-16 | Michael Ellenbogen | Co-Founder, Chief Innovation Officer & Director | Derivative Exercise and Sale | -80,752 | $0.24–5.59 |
| 2026-08-13 | Neil Glat | Independent Director | Open Market Acquisition | +8,500 | $5.74 |
| 2026-08-13 | Henrik Kuhl | Independent Director | Open Market Acquisition | +15,000 | $5.73 |
| 2026-07-15 | Kevin Charlton | Independent Director | Sale to Issuer | -67,500 | -- |
| 2026-07-15 | Neil Glat | Independent Director | Sale to Issuer | -32,591 | -- |
| 2026-07-14 | Michael Ellenbogen | Co-Founder, Chief Innovation Officer & Director | Derivative Exercise and Sale | -80,745 | $0.24–5.94 |
| 2026-06-17 | Richard Shapiro | Director | Other Derivative Acquisition | +28,318 | -- |
| 2026-06-17 | Kevin Charlton | Independent Director | Other Derivative Acquisition | +28,318 | -- |
| 2026-06-17 | Michael Ellenbogen | Co-Founder, Chief Innovation Officer & Director | Other Derivative Acquisition | +28,318 | -- |
| 2026-06-17 | Kimberly Sheehy | Independent Director | Other Derivative Acquisition | +28,318 | -- |
| 2026-06-17 | Neil Glat | Independent Director | Other Derivative Acquisition | +28,318 | -- |
| 2026-06-17 | Henrik Kuhl | Independent Director | Other Derivative Acquisition | +28,318 | -- |
| 2026-06-16 | Richard Shapiro | Director | Derivative Exercise and Retained | +27,050 | -- |
| 2026-06-16 | Kevin Charlton | Independent Director | Derivative Exercise and Retained | +27,050 | -- |
| 2026-06-16 | Kimberly Sheehy | Independent Director | Derivative Exercise and Retained | +27,050 | -- |
| 2026-06-16 | Mark Sullivan | Independent Director | Derivative Exercise and Retained | +27,050 | -- |
| 2026-06-16 | Neil Glat | Independent Director | Derivative Exercise and Retained | +27,050 | -- |
| 2026-06-16 | David Gonzales | Director | Derivative Exercise and Retained | +27,050 | -- |
| 2026-06-16 | Henrik Kuhl | Independent Director | Derivative Exercise and Retained | +9,291 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 10:00:17 · For reference only, not investment advice and not tailored to your situation.